US delays pharma tariffs to push for more drug pricing deals

Published on October 2, 2025

See on Internet Archive

by
Swissinfo
My articles My site About me My videos My books
Follow on:Twitter Facebook Google +

According to government circles, the new tariffs on pharmaceutical imports into the US announced by US President Donald Trump for October 1 will not be imposed after all. This was announced by a high-ranking government official to the German Press Agency. +Get the most important news from Switzerland in your inbox Instead, tariffs are now being prepared against pharmaceutical companies that do not want to relocate their production to the US or lower prices. No specific reasons for the postponement were given. Last week, President Trump surprised many experts by announcing new tariffs. From October 1, imports of branded and patented medicines into the US were to be subject to a 100% surcharge. Pharmaceutical manufacturers who build a production facility in the US would be able to avoid the tariff. He left the details open. + How pharma became Switzerland’s Achilles heel in the US Swiss pharma invests billions in the US Swiss pharmaceutical companies had already announced investment ... Full story here Are you the author?

About Swissinfo

SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC). Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.

My articles My site About me My books
Follow on:Twitter Facebook Google +